Cytokinetics Inc (CYTK) Dividend History
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998.
Last update 12/11/2023
Dividend Yield Summary
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
Dividends | - | - | - | - | - | - |
Average Price | 9.90 | 18.34 | 28.32 | 41.79 | 36.29 | - |
Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
Date | Amount Per Share | Note |